Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Vanessa A. Sanders"'
Publikováno v:
Current Radiopharmaceuticals. 16:95-106
Abstract: In recent years, there has been an increased interest in 44Ti/44Sc generators as an onsite source of 44Sc for medical applications without needing a proximal cyclotron. The relatively short half-life (3.97 hours) and high positron branching
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 192
Several hydroxamate-based resins were synthesized and tested for use in
Autor:
Mona Purcell, Carmen Azevedo, Jenny N. Ijoma, Savita Dhanvantari, Patrícia M. R. Pereira, Xiaowei Wang, Oluwatosin Y. Ibhagui, Aisling Chaney, Kyeara N. Mack, Veronica L. Nagle, Oluwatayo F. Ikotun, Vanessa A. Sanders, Eman A. Akam, Monica Shokeen, Kelly E. Henry, Kimberly J. Edwards
Publikováno v:
Molecular Imaging and Biology
Recent events in America in 2020 have stimulated a worldwide movement to dismantle anti-Black racism in all facets of our lives. Anti-Black racism is, as defined by the Movement for Black Lives, a "term used to specifically describe the unique discri
Publikováno v:
Applied Radiation and Isotopes. 192:110588
Autor:
Cathy S. Cutler, Vanessa A. Sanders, Mohammed Z. Rahman, Lynn C. Francesconi, Jasmine L. Hatcher-Lamarre
Publikováno v:
Nucl Med Biol
Targeted alpha therapy (TAT) is an area of research with rapidly increasing importance as the emitted alpha particle has a significant effect on inducing cytotoxic effects on tumor cells while mitigating dose to normal tissues. Two significant isotop
Autor:
Cathy S. Cutler, Vanessa A. Sanders
Publikováno v:
Nuclear Medicine and Biology. 92:184-201
Molecular imaging is a non-invasive process that enables the visualization, characterization, and quantitation of biological processes at the molecular and cellular level. With the emergence of theragnostic agents to diagnose and treat disease for pe
Publikováno v:
Bioconjugate chemistry. 32(7)
The continual development of radiopharmaceutical agents for the field of nuclear medicine is integral to promoting the necessity of personalized medicine. One way to greatly expand the selection of radiopharmaceuticals available is to broaden the ran
Autor:
Jason S. Lewis, Lukas M. Carter, Suzanne E. Lapi, Adriana V.F. Massicano, Corey Cutler, Vanessa A. Sanders, Edwin C. Pratt, Adam Kesner
Publikováno v:
Mol Imaging Biol
PURPOSE: The increasing interest and availability of non-standard positron-emitting radionuclides has heightened the relevance of radionuclide choice in the development and optimization of new positron emission tomography (PET) imaging procedures, bo
Publikováno v:
Current Colorectal Cancer Reports. 13:470-480
The prognosis of colorectal carcinoma with liver metastases (CRLM) is driven largely by the resectability of hepatic metastatic disease. An increasing number of systemic and hepatic-directed therapies are being applied in the neoadjuvant setting to d
Autor:
Vanessa A. Sanders, David Iskhakov, Dalya Abdel-Atti, Matthew Devany, Kenneth R. Czerwinski, Michelle C. Neary, Lynn C. Francesconi
Publikováno v:
Nuclear medicine and biology.
A pentapeptide macrocyclic ligand, KYCAR (lysyl-tyrosyl-cystyl-alanyl-arginine), has been designed as a potential chelating ligand for SPECT imaging and therapeutic in vivo agents. This study shows the synthesis and characterization of KYCAR complexe